Company intelligence / Profile preview

Mana Capital Acquisition Corp

Dover, Delaware, United Statessec.gov ↗

Ownership: Private
Development stage: Commercial

Overview

Mana Capital Acquisition Corp was a blank check company formed to merge with or acquire another business. In October 2022, it completed its business combination with Cardio Diagnostics Holdings, Inc., after which the combined entity began trading as Cardio Diagnostics on Nasdaq[4][5][6][8].

Industry: Investors

Drug pipeline

1 asset

Epi+Gen CHD

Commercial

Indications: Coronary heart disease

Partnerships

The main transaction was the merger with Cardio Diagnostics Holdings

Beyond the preview

Go deeper on Mana Capital Acquisition Corp.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mana Capital Acquisition Corp.

Explore the full profile